March 12, 2025
LEAST Study to Test Type 2 Diabetes Medication for Stroke Recovery
PHRI researchers are looking into whether liraglutide, a widely used medication for type 2 diabetes, could benefit patients with large...
Read More
March 7, 2025
OCEANIC-STROKE Completes Recruitment, Exceeds Target
PHRI’s OCEANIC-STROKE study has successfully completed recruitment enrolling approximately 12,300 patients across 38 countries, surpassing its initial target of 9,300...
Read More
February 25, 2025
CLARITY for Better Chronic Limb-Threatening Ischemia Treatment
PHRI has received a $244,800 grant from the Canadian Institutes of Health Research (CIHR) for a new study that aims...
Read More
February 10, 2025
PHRI at ISC 2025
Several PHRI researchers presented at the International Stroke Congress (ISC) 2025, held in Los Angeles, California, from February 5-7, 2025. ...
Read More
February 6, 2025
Secondary CVD Medications Remain Underused Globally
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read More
February 3, 2025
Apixaban Reduces Stroke Risk More Than It Increases Bleeding in Stroke Survivors
An analysis of the ARTESiA study found that the blood thinner apixaban helps prevent stroke in people with device-detected subclinical...
Read More